Addition of Sintilimab to Nanoparticle Albumin-Bound Paclitaxel and S-1 as Adjuvant Therapy in Stage IIIC Gastric Cancer
Yu Mei(Shanghai Jiao Tong University), Zhenglun Zhu(Brigham and Women's Hospital), Jun Zhang(Qingdao University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Tienan Feng(Shanghai Jiao Tong University), Hong Yuan(People's Hospital of Xinjiang Uygur Autonomous Region), Chen Li(Shanghai Jiao Tong University), Min Shi(Hebei Medical University), Min Yan(Zhengzhou University)
Cited by 7
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298